Company Filing History:
Years Active: 2003
Title: Masamitsu Iino: Innovator in Inositol Receptor Ligands
Introduction: Masamitsu Iino is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that interact with inositol receptors. His work has implications for various biological processes and potential therapeutic applications.
Latest Patents: Masamitsu Iino holds a patent for Ip3 receptor ligands. The patent describes a compound represented by the general formula (I) or a salt thereof. In this formula, R represents a group defined by specific alkyl and amino structures, while X represents an anion. This compound is useful as a ligand for inositol-1,4,5-trisphosphate (IP3) receptors, which play a crucial role in cellular signaling.
Career Highlights: Throughout his career, Masamitsu Iino has focused on innovative research that bridges chemistry and biology. His work has led to advancements in understanding how certain compounds can modulate receptor activity, which is vital for developing new therapeutic strategies.
Collaborations: Masamitsu Iino has collaborated with notable colleagues, including Tetsuo Nagano and Kazuya Kikuchi. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion: Masamitsu Iino's contributions to the field of biochemistry, particularly through his patent on Ip3 receptor ligands, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications related to cellular signaling.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.